BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21938584)

  • 1. Laparoscopic resection of a residual retroperitoneal tumor mass of nonseminomatous testicular germ cell tumors.
    Oztürk C; van Ginkel RJ; Krol RM; Gietema JA; Hofker HS; Hoekstra HJ
    Surg Endosc; 2012 Feb; 26(2):458-67. PubMed ID: 21938584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic Resection of Residual Retroperitoneal Tumor Mass in Advanced Nonseminomatous Testicular Germ Cell Tumors; a Feasible and Safe Oncological Procedure.
    Öztürk Ç; Been LB; van Ginkel RJ; Gietema JA; Hoekstra HJ
    Sci Rep; 2019 Nov; 9(1):15837. PubMed ID: 31676840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified.
    Gels ME; Hoekstra HJ; Sleijfer DT; Nijboer AP; Molenaar WM; Ebels T; Schraffordt Koops H
    Chest; 1997 Oct; 112(4):967-73. PubMed ID: 9377960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
    Paffenholz P; Pfister D; Heidenreich A
    Urologe A; 2016 May; 55(5):632-40. PubMed ID: 26820659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.
    Sonneveld DJ; Sleijfer DT; Koops HS; Keemers-Gels ME; Molenaar WM; Hoekstra HJ
    Cancer; 1998 Apr; 82(7):1343-51. PubMed ID: 9529027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes.
    Arai Y; Kaiho Y; Yamada S; Saito H; Mitsuzuka K; Yamashita S; Namiki S; Nakagawa H; Ishidoya S; Ito A
    Int Urol Nephrol; 2012 Oct; 44(5):1389-95. PubMed ID: 22648291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of the post-chemotherapy resection of retroperitoneal residual tumour mass in patients with non-seminomatous testicular germ cell tumours.
    Gels ME; Nijboer AP; Hoekstra HJ; Sleijfer DT; Molenaar WM; Plukker JT; Droste JH; Schraffordt Koops H
    Br J Urol; 1997 Feb; 79(2):263-8. PubMed ID: 9052480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors infiltrating the great vessels.
    Aufderklamm S; Todenhöfer T; Hennenlotter J; Mischinger J; Böttge J; Rausch S; Halalsheh O; Stenzl A; Gakis G; Schwentner C
    J Endourol; 2014 Jun; 28(6):668-74. PubMed ID: 24422683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
    Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
    J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor.
    Blok JM; van der Poel HG; Kerst JM; Bex A; Brouwer OR; Bosch JLHR; Horenblas S; Meijer RP
    World J Urol; 2021 Jun; 39(6):1969-1976. PubMed ID: 32955662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
    Herr HW; Toner GC; Geller NL; Bosl GJ
    Eur Urol; 1991; 19(1):1-5. PubMed ID: 1848821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic resection of paraaortic or paracaval lesions: feasibility and outcome.
    Chung L; O'Dwyer PJ
    Surg Endosc; 2013 Nov; 27(11):4153-6. PubMed ID: 23860605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for the histologic nature of residual tumor mass after chemotherapy in patients with advanced testicular cancer.
    Matsuyama H; Yamamoto N; Sakatoku J; Suga A; Hayashida S; Kamiryo Y; Nagata K; Naito K
    Urology; 1994 Sep; 44(3):392-8; discussion 398-9. PubMed ID: 8073552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood testis barrier revisited-Analysis of post-chemotherapy germ cell tumor orchidectomy and retroperitoneal lymph node dissection specimens.
    Gupta A; Noronha J; Bakshi G; Menon S; Pal M; Joshi A; Prabash K; Noronha V; Murthy V; Krishnattry R; Patil A; Prakash GJ
    J Surg Oncol; 2021 Mar; 123(4):1157-1163. PubMed ID: 33428791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.